The diagnostics technology developer has raised another $290m from existing investor Roche, which will support it as it looks to expand its products to additional cancers.

Synthetic DNA producer DNA Script and personalised health plan provider Transcarent each closed $200m corporate-backed series C rounds.

The footfall analytics software developer scored a $1bn valuation through a series C round featuring Majestic Realty, the latest real estate operator to invest in the property data sector.

Business-focused neobank Qonto raised $552m from investors including Tencent at a $552m valuation while SK provided $350m for Center for CDMO Breakthrough Medicines.

MassMutual Ventures was among the participants as Zluri became the latest software-as-a-service management platform developer to raise money.

Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.

All existing shareholders including Alexandria Venture Investments contributed to the RNA drug developer’s series B round, following a $91.5m series A in mid-2020.

Comcast Ventures and BDMI are set to record profitable exits through the deal, showing the new models of digital media can still make for inviting investments.

Manulife and Shell helped the solar power provider raise the cash as Exelon-backed residential solar energy supplier PosiGen secured $100m, showing continuing interest in the solar power space.

Nexon has invested $400m in film and television studio Agbo while responsible credit card provider Petal raised $140m in an Encore Bank and Cuna Mutual-backed round.